Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parsons Medical Communications was a specialized medical communications and scientific strategy company focused exclusively on eyecare. The company provided services such as scientific strategy, peer-to-peer education, advocacy development, content creation, conference and association planning, market landscape assessments, and broader medical communications support for biopharma clients. Founded by Erin Parsons in the Boston area, PMC built a niche position in ophthalmology and related therapeutic areas rather than developing proprietary therapeutics. In September 2022, the company was acquired by Fingerpaint Group and integrated into Fingerpaint’s Specialty Services organization, where it continued as part of a broader healthcare communications platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parsons Medical Communications.